Board of Directors

Mr. Polygenis joined McKesson Canada in 2004, after the acquisition of Phase 4 Health. This acquisition led to the creation of our Specialty group. Under the leadership of Dimitris Polygenis, the group expanded its services to become our fastest growing business offering a wide range of services to manufacturers. Mr. Polygenis was appointed to his current role in 2014.

Prior to joining McKesson Canada, Mr. Polygenis held a position with the Ontario Round Table on Appropriate Prescribing (ORTAP) at the Institute for Clinical Evaluative Sciences in Ontario (ICES). He is currently Lecturer and Clinical Assistant Professor at the University of Toronto and University of British Columbia Doctor of Pharmacy Programs and Board Chair of a not-for-profit educational institution.

Mr. Polygenis holds a Doctor of Pharmacy Degree from the University of Toronto.

uniPHARM Wholesale Drugs Ltd. has been recognized as one of Canada’s Best Managed companies and has been a Platinum member for the past 4 years.

Today, John is also actively involved in numerous strategic initiatives and has a broad range of experience in various areas of logistics, purchasing and operations.  He continues to serve on multiple CAPDM committees with other industry colleagues to improve the distribution of products to Canadians.

Kohl & Frisch Limited is an independent, family owned business established in 1916. Ron Frisch became its Chief Executive Officer in 1989. He also accepted the positions of President & Managing Director in 2001. Mr. Frisch is a Chartered Accountant and holds a BCom from the University of Toronto. He is a member of the Young Presidents Organization and a four-time appointed Chairman of the Board for CAPDM. Ron Frisch is active in the community and is involved in many charity and educational endeavours.

Kohl & Frisch Limited is the only Canadian-owned national full-line distributor.

Tanya Moore has spent the last fifteen years in the healthcare sector, specifically with Shoppers Drug Mart. Occupying many senior roles, Tanya has gained valuable insights into procurement, distribution, operations, insurance, strategy and pricing. Harnessing this broad background, Tanya brings a deep understanding of the pharmacy supply chain to her role on the CAPDM board as well as being a standing member on the GS1 Healthcare Pharmacy board.

Before starting HealthForward, Kevin led various divisions at Innomar, including Consulting, Pharmacy, Distribution, Government Relations, Strategic Partnerships, New Business Development and Marketing.  Prior to joining Innomar, Kevin spearheaded many innovative and ground-breaking initiatives that have shaped the delivery of healthcare in Canada.  He implemented Canada’s first electronic prescription claims adjudication system and launched a fully-integrated adjudication software.  He also led the first US owned long-term care pharmacy in Canada.   

Kevin holds a Bachelor of Arts degree from York University.

In addition to building high performing teams and creating award-winning programs, she has a proven track record in driving sustainable growth and innovation to inspire change. Angelique has served on multi-sector collaborations that accelerated health care system and patient care improvements, including the Wait Times Alliance, the Bone and Joint Decade Canada, Health Quality Ontario’s Hypertension Quality Standard Advisory Committee, and Health Canada’s Multi-Stakeholder Committee on Drug Shortages.

She also served on the board of the Best Medicines Coalition, and for over 10 years as a member of the Health Charities Coalition of Canada.”

She is a member of Imperial’s Leadership Team working closely with stakeholders to formulate strategic objectives and build long-term partnerships. Joan proactively develops a deep understanding of the business landscape and identifies value added opportunities and facilitates implementation. Her reputation is predicated on a track record of achieving results.

Prior to joining Imperial in 2022, Joan held senior executive and management positions in Western Canada with two other leading national pharmaceutical wholesale distributors.

Prior to Bayer, Erik was at Allergan where he was the Executive Director of Business Insights and Commercial Excellence, leading a large multi-function international team spanning Canada and Latin America. Other key roles involved leading supply chain, commercial operations, and sales & marketing operations.  

Erik spent his early career within the high-tech sector at Nortel Networks with roles in customer operations, manufacturing, supply chain, and process engineering.

Erik has been a member of CAPDM since 2003. He has a degree in Mechanical Engineering from Queens University, holds Professional Engineering and Certified Financial Planner designations, and is now completing his MBA. 
 

Under his leadership, Sandoz Canada has grown to become one of the largest pharmaceutical companies in the country with more than 60 million prescriptions per year of generic and biosimilar products. Sandoz is among the Top 35 Employers in Montreal and among the “Best Place to Work” companies in the country.

Mr. Robidoux began his sales and marketing career at Bayer Canada for more than seven years and then held senior positions at Roche in the Diabetes Care, Clinical Diagnostics and Applied Science Divisions.

He is an active contributor to the Canadian pharmaceutical industry as a member of the Canadian Generic Pharmaceutical Association (CGPA), Chair of Biosimilar Canada and a member of the Board of Directors of the Canadian Association of Pharmaceutical Supply Management (CAPDM).

Mr. Robidoux holds a Bachelor degree in Business Administration from the Université du Québec in Montreal and has an A.S.C. (certified company administrator) designation from the Collège des administrateurs de sociétés of Université Laval.
 

Hugues Mousseau is a management consultant with 20 years of experience in corporate affairs and communications in the public and private sectors. Hugues holds university degrees in political science, business administration and public law.